Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CPAH

CounterPath (CPAH) Stock Price, News & Analysis

CounterPath logo

About CounterPath Stock (NASDAQ:CPAH)

Advanced Chart

Key Stats

Today's Range
$3.47
$3.49
50-Day Range
$3.44
$3.49
52-Week Range
$1.84
$5.92
Volume
74,600 shs
Average Volume
31,350 shs
Market Capitalization
$22.41 million
P/E Ratio
34.80
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CPAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CounterPath and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CPAH Stock News Headlines

Think Out Loud
Why CounterPath (CPAH) Stock Is Soaring Today
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
See More Headlines

CPAH Stock Analysis - Frequently Asked Questions

CounterPath Co. (NASDAQ:CPAH) posted its quarterly earnings data on Wednesday, December, 14th. The software maker reported ($0.12) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by $0.02. The software maker had revenue of $2.75 million for the quarter, compared to the consensus estimate of $3.30 million. CounterPath had a trailing twelve-month return on equity of 25.68% and a net margin of 5.30%.

Based on aggregate information from My MarketBeat watchlists, some other companies that CounterPath investors own include FuelCell Energy (FCEL), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), VBI Vaccines (VBIV) and XTI Aerospace (XTIA).

Company Calendar

Last Earnings
12/14/2016
Today
8/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged Software
Sub-Industry
N/A
Current Symbol
NASDAQ:CPAH
CIK
1236997
Fax
N/A
Employees
72
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
34.80
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.10 million
Net Margins
5.30%
Pretax Margin
N/A
Return on Equity
25.68%
Return on Assets
5.61%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.60
Quick Ratio
0.60

Sales & Book Value

Annual Sales
$12.10 million
Price / Sales
1.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.33 per share
Price / Book
10.55

Miscellaneous

Outstanding Shares
6,440,000
Free Float
N/A
Market Cap
$22.41 million
Optionable
Not Optionable
Beta
1.76
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:CPAH) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners